|
|
|
| Vaccines in the News |
|
| Media coverage about vaccines and vaccine-preventable diseases |
|
| Diphtheria |
|
|
|
|
|
|
FDA Approves GlaxoSmithKline Tetanus, Diphtheria, Whooping Cough
Vaccine, BOOSTRIX®, for Adults; New Indication for Booster Vaccine
Expands Disease Protection to Individuals Aged 10-64 Years |
|
| Market Wire |
|
| December 8, 2008 |
|
| "GlaxoSmithKline (NYSE: GSK)
announced today that the U.S. Food and Drug Administration (FDA) has
approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 19-64
years of age. BOOSTRIX offers protection against tetanus, diphtheria and
pertussis (whooping cough) to individuals 10-64 years of age -- the
broadest age range for any Tdap vaccine..." |
|
| Hospitals Vaccinating Parents of High-Risk Infants |
|
| Reuters |
|
| September 9, 2008 |
|
| "New research suggests that the newborn (neonatal) intensive care unit (NICU) is a good setting for offering the tetanus, diphtheria, and acellular pertussis vaccine (TdaP) to the parents of high-risk infants to protect them against common childhood infections..." |
|
|
|
|
|
|
|
| Immunization Action Coalition • 1573 Selby Avenue • Saint Paul, MN 55104 |
|
| tel 651-647-9009 • fax 651-647-9131 |
|
| email admin@immunize.org |
|
IAC Home